Claudia Ibarra
Geschäftsführer bei DermTech Operations, Inc.
Vermögen: 113 225 $ am 30.04.2024
Profil
Claudia Ibarra is currently the Chief Operating Officer at DermTech Operations, Inc. She previously worked as the Director-Molecular Oncology Laboratory at Genoptix, Inc. from 2006 to 2012, and as the Vice President-Laboratory Operations at Exagen, Inc. from 2012 to 2019.
In 2019, she became the Chief Operating Officer at DermTech, Inc. Ms. Ibarra received her undergraduate degree from Universidad de Buenos Aires.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
DERMTECH, INC.
0,56% | 11.12.2023 | 193 547 ( 0,56% ) | 113 225 $ | 30.04.2024 |
Aktive Positionen von Claudia Ibarra
| Unternehmen | Position | Beginn |
|---|---|---|
DermTech Operations, Inc.
 DermTech Operations, Inc. Medical SpecialtiesHealth Technology DermTech Operations, Inc. engages in the provision of molecular dermatology. It develops products that facilitate the early detection of skin cancers, assess inflammatory diseases, and customize drug treatments. The firm's products include adhesive skin collection kit, pigmented lesion assay (PLA), nevome, inflammatory disease and carcinome. The company was founded by Lawrence A. Rheins in 1996 and is headquartered in La Jolla, CA. | Geschäftsführer | - |
Ehemalige bekannte Positionen von Claudia Ibarra
| Unternehmen | Position | Ende |
|---|---|---|
| DERMTECH, INC. | Geschäftsführer | 02.02.2024 |
| EXAGEN INC. | Geschäftsführer | 10.11.2014 |
Genoptix, Inc.
 Genoptix, Inc. Medical SpecialtiesHealth Technology Genoptix, Inc. provides specialized oncology diagnostics services. It offers a range of customizable clinical trial, custom assay development and companion diagnostics development services. The company was founded in 1999 by Tina S. Nova and is headquartered in Carlsbad, CA. | Corporate Officer/Principal | 01.02.2012 |
Ausbildung von Claudia Ibarra
| Universidad de Buenos Aires | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| EXAGEN INC. | Health Services |
| DERMTECH, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Genoptix, Inc.
Genoptix, Inc. Medical SpecialtiesHealth Technology Genoptix, Inc. provides specialized oncology diagnostics services. It offers a range of customizable clinical trial, custom assay development and companion diagnostics development services. The company was founded in 1999 by Tina S. Nova and is headquartered in Carlsbad, CA. | Health Technology |
DermTech Operations, Inc.
DermTech Operations, Inc. Medical SpecialtiesHealth Technology DermTech Operations, Inc. engages in the provision of molecular dermatology. It develops products that facilitate the early detection of skin cancers, assess inflammatory diseases, and customize drug treatments. The firm's products include adhesive skin collection kit, pigmented lesion assay (PLA), nevome, inflammatory disease and carcinome. The company was founded by Lawrence A. Rheins in 1996 and is headquartered in La Jolla, CA. | Health Technology |
